Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
InnoCare Optoelectronics's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 59.68%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for InnoCare Optoelectronics's 3-Year ROIIC % or its related term are showing as below:
TPE:6861's 3-Year ROIIC % is ranked better than 84.63% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 1.455
vs TPE:6861: 59.68
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
InnoCare Optoelectronics 3-Year ROIIC % Related Terms
InnoCare Optoelectronics 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6861 vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, InnoCare Optoelectronics's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCare Optoelectronics 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InnoCare Optoelectronics's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where InnoCare Optoelectronics's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
InnoCare Optoelectronics (TPE:6861) has a 3-Year ROIIC % of 59.68 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on InnoCare Optoelectronics and its competitors. According to the industry distribution chart, InnoCare Optoelectronics ranks #122 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 15.4%.
Is InnoCare Optoelectronics' 3-Year ROIIC % too high?
InnoCare Optoelectronics' current 3-Year ROIIC % is 59.68. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.46. InnoCare Optoelectronics' value of 59.68 is 4001.7% above this industry median. Based on the distribution chart, InnoCare Optoelectronics ranks #122 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, InnoCare Optoelectronics has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InnoCare Optoelectronics ranks #122 out of 794 companies for 3-Year ROIIC %. This places InnoCare Optoelectronics in the top 15% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.46. InnoCare Optoelectronics' value of 59.68 is 4001.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.46, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCare Optoelectronics's current 3-Year ROIIC % of 59.68 is 4001.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on InnoCare Optoelectronics and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCare Optoelectronics's current 3-Year ROIIC % is 59.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$85.90, compared to a current price of NT$207.00 — trading 141% above its estimated fair value. The current 3-Year ROIIC % is 59.68 and 4001.7% above the Medical Devices & Instruments industry median of 1.46. InnoCare Optoelectronics' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current 3-Year ROIIC % is 59.68 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued.
The current stock price of NT$207.00 is trading 141% above its estimated GF Value™ of NT$85.90.
GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.
Key valuation signals for TPE:6861:
3-Year ROIIC %: 59.68
GF Value™: NT$85.90 vs. price of NT$207.00 (141% above fair value)
Industry Position: 4001.7% above the Medical Devices & Instruments median (#122 of 794)
No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
66GF Score
Get the complete analysis for TPE:6861
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6861 has been successfully added to your 
